Literature DB >> 19654994

Transfusion and risk of infection in Canada: UPDATE 2004.

.   

Abstract

Entities:  

Year:  2004        PMID： 19654994      PMCID： PMC2720478          DOI： 10.1093/pch/9.3.145

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  15 in total

Review 1.  The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1.

Authors:  E Tabor
Journal:  Transfusion       Date:  1999 Nov-Dec       Impact factor: 3.157

Review 2.  Bacterial contamination of blood components.

Authors:  J Seghatchian
Journal:  Transfus Apher Sci       Date:  2001-10       Impact factor: 1.764

Review 3.  Virus safety of human blood, plasma, and derived products.

Authors:  Lutz Guertler
Journal:  Thromb Res       Date:  2002-10-31       Impact factor: 3.944

4.  Inactivation of parvovirus B19 during pasteurization of human serum albumin.

Authors:  Johannes Blümel; Ivo Schmidt; Hannelore Willkommen; Johannes Löwer
Journal:  Transfusion       Date:  2002-08       Impact factor: 3.157

Review 5.  West Nile virus.

Authors:  Lyle R Petersen; Anthony A Marfin; Duane J Gubler
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

6.  Thawing fresh frozen plasma in a microwave oven. A comparison with thawing in a 37 degrees C waterbath.

Authors:  W H Churchill; B Schmidt; J Lindsey; M Greenberg; S Boudrow; C Brugnara
Journal:  Am J Clin Pathol       Date:  1992-02       Impact factor: 2.493

Review 7.  Risks associated with transfusion of cellular blood components in Canada.

Authors:  Steven Kleinman; Penny Chan; Pierre Robillard
Journal:  Transfus Med Rev       Date:  2003-04

8.  Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002.

Authors:  Brad J Biggerstaff; Lyle R Petersen
Journal:  Transfusion       Date:  2003-08       Impact factor: 3.157

9.  The risk of transfusion-acquired CMV infection in seronegative solid-organ transplant recipients receiving non-WBC-reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center.

Authors:  Jutta K Preiksaitis; Jatinder Sandhu; Maureen Strautman
Journal:  Transfusion       Date:  2002-04       Impact factor: 3.157

10.  Blood-bank testing for infectious diseases: how safe is blood transfusion?

Authors:  D Michael Strong; Louis Katz
Journal:  Trends Mol Med       Date:  2002-07       Impact factor: 11.951
View more
  2 in total

1.  Transfusion and risk of infection in Canada: Update 2005.

Authors:  Noni Macdonald
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-05       Impact factor: 2.471

2.  Transfusion and risk of infection in Canada: Update 2005.

Authors: 
Journal:  Paediatr Child Health       Date:  2005-03       Impact factor: 2.253
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.